alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
exv10w63






Exhibit 10.63




Compensation Arrangements for the Named Executive Officers



Set forth below is a summary of the compensation paid by Goodrich Corporation (the “Company”) to
its named executive officers (defined in Regulation S-K Item 402(a)(3)) in their current positions
as of the date of filing of the Company’s Annual Report on Form 10-K for the year ended December
31, 2010 (the “Form 10-K”). All of the Company’s executive officers are at-will employees whose
compensation and employment status may be changed at any time in the discretion of the Company’s
Board of Directors, subject only to the terms of the Management Continuity Agreements between the
Company and these executive officers, the form of which is filed as Exhibit 10.49 to the Form 10-K.



Base Salary. Effective January 1, 2011, the named executive officers are to receive the following
annual base salaries in their current positions:




	 	 	 	 	 
	Name and Current Position	 	Base Salary ($)
	Marshall O. Larsen

(Chairman, President and Chief Executive Officer)

	 	$	1,200,000	 
	Scott E. Kuechle

(Executive Vice President and Chief Financial Officer)

	 	$	535,000	 
	Terrence G. Linnert 

(Executive Vice President, Administration and General Counsel)

	 	$	526,000	 
	John J. Carmola

(Vice President and Segment President, Actuation & Landing Systems)

	 	$	535,000	 
	Cynthia M. Egnotovich

(Vice President and Segment President, Nacelles and Interior Systems)

	 	$	535,000	 





Annual and Long-Term Incentive Plans. In their current positions, the named executive officers
are eligible to:





	•	 	Receive an annual cash incentive award pursuant to the Senior Executive Management
Incentive Plan (filed as Exhibit 10.34 to the Form 10-K).
	 
	•	 	Participate in the Company’s long-term incentive program, which currently involves the
award of restricted stock units, stock options and performance units pursuant to the Company’s
2001 Equity Compensation Plan (filed as Exhibit 10.8 to the Form 10-K).




 









 










Benefit Plans and Other Arrangements. In their current positions, the named executive officers are
eligible to:





	•	 	Participate in the Company’s broad-based benefit programs generally available to its
salaried employees, including health, disability and life insurance programs, qualified 401(k)
and pension plans and a severance plan.
	 
	•	 	Participate in non-qualified 401(k) and pension plans (filed as Exhibits 10.37, 10.38 and
10.39 to the Form 10-K), a supplemental executive retirement plan (the form of which is filed
as Exhibit 10.36 to the Form 10-K), a management continuity agreement that takes effect upon a
change in control of the Company (the form of which is filed as Exhibit 10.49 to the Form
10-K).
	 
	•	 	Receive the following perquisites: financial counseling and tax preparation; annual
physical examinations for the executive and spouse; in certain cases, home security systems;
and limited personal use of the Company’s aircraft.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          NOV-30-1996
<PERIOD-START>                             DEC-01-1996
<PERIOD-END>                               FEB-28-1997
<CASH>                                          11,659
<SECURITIES>                                         0
<RECEIVABLES>                                    3,053
<ALLOWANCES>                                         0
<INVENTORY>                                         78
<CURRENT-ASSETS>                                18,363
<PP&E>                                          33,367
<DEPRECIATION>                                   4,688
<TOTAL-ASSETS>                                  53,271
<CURRENT-LIABILITIES>                           10,205
<BONDS>                                         22,932
<PREFERRED-MANDATORY>                            2,500
<PREFERRED>                                          0
<COMMON>                                        15,544
<OTHER-SE>                                       1,162
<TOTAL-LIABILITY-AND-EQUITY>                    53,271
<SALES>                                              0
<TOTAL-REVENUES>                                   403
<CGS>                                                0
<TOTAL-COSTS>                                    (223)
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (241)
<INCOME-PRETAX>                                (1,211)
<INCOME-TAX>                                       447
<INCOME-CONTINUING>                              (764)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (764)
<EPS-PRIMARY>                                    (.22)
<EPS-DILUTED>                                    (.22)
        

</TABLE>
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2660 Reported in Senate (RS)]

                                                       Calendar No. 376
112th CONGRESS
  2d Session
                                H. R. 2660

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           November 17, 2011

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

                             April 25, 2012

              Reported by Mr. Lieberman, without amendment

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
at 122 North Holderrieth Boulevard in Tomball, Texas, as the ``Tomball 
                        Veterans Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TOMBALL VETERANS POST OFFICE.

    (a) Designation.--The facility of the United States Postal Service 
located at 122 North Holderrieth Boulevard in Tomball, Texas, shall be 
known and designated as the ``Tomball Veterans Post Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Tomball 
Veterans Post Office''.
                                                       Calendar No. 376

112th CONGRESS

  2d Session

                               H. R. 2660

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
at 122 North Holderrieth Boulevard in Tomball, Texas, as the ``Tomball 
                        Veterans Post Office''.

_______________________________________________________________________

                             April 25, 2012

                       Reported without amendment
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                   71,626
<ALLOWANCES>                                   (2,511)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                75,661
<PP&E>                                          94,157
<DEPRECIATION>                                (32,558)
<TOTAL-ASSETS>                                 322,209
<CURRENT-LIABILITIES>                           59,917
<BONDS>                                        119,689
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           397
<OTHER-SE>                                     135,191
<TOTAL-LIABILITY-AND-EQUITY>                   322,209
<SALES>                                         78,680
<TOTAL-REVENUES>                                78,680
<CGS>                                           61,229
<TOTAL-COSTS>                                   79,102
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,487
<INCOME-PRETAX>                                (3,909)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (3,909)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,909)
<EPS-BASIC>                                      (.12)
<EPS-DILUTED>                                    (.12)


</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                         159,932
<SECURITIES>                                 5,633,921
<RECEIVABLES>                                    5,260
<ALLOWANCES>                                         0
<INVENTORY>                                    654,603
<CURRENT-ASSETS>                             6,567,810
<PP&E>                                       2,522,154
<DEPRECIATION>                                (261,497)
<TOTAL-ASSETS>                               9,141,834
<CURRENT-LIABILITIES>                        1,692,229
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        77,831
<OTHER-SE>                                   7,348,292
<TOTAL-LIABILITY-AND-EQUITY>                 9,141,834
<SALES>                                         62,194
<TOTAL-REVENUES>                                75,157
<CGS>                                                0
<TOTAL-COSTS>                                1,891,831
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (1,753,760)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (1,753,760)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (1,753,760)
<EPS-PRIMARY>                                    (0.23)
<EPS-DILUTED>                                    (0.23)
        



</TABLE>
Extension Agreement for Related Party Debenture issued to Michael Macaluso



 Exhibit 10.3 
 AMPIO PHARMACEUTICALS, INC. 
 EXTENTION AGREEMENT FOR NOTES PAYABLE

 TOTAL PRINCIPAL AMOUNT: $230,000 
 Effective Date: January 31, 2011 
 Greenwood Village, CO 80111 

On August 12, 2010 and August 16, 2010, the undersigned Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Maker”), issued two
promissory notes (the “Notes”) in the amounts of $30,000.00 and $200,000.00, respectively, and promised to pay to the order of Michael Macaluso, and his successors or assigns (collectively, the “Holder”), the aggregate sum of
$230,000.00 due under the Notes, together with interest at the rate of 8.0% (eight percent) per annum until the Notes are paid in full. The Notes were originally due on January 31, 2011. 
 In consideration of this extension agreement, the payment of $100, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted by the Holder and
the Maker, the Maker and the Holder hereby agree to extend the due date of the Notes to the earlier of (i) closing of a public or private equity financing (the “Offering”) in an amount exceeding $5 million, or (ii) April 30,
2011. All of the other terms of the original Notes remain unchanged. 
 Maker may prepay the Notes in part, or in full, prior to the due date of
the Notes. Payments of principal and interest shall be made at the place that Holder from time to time shall direct in writing. 
 In witness
whereof, the parties hereto have executed this Extension Agreement for Notes Payable, to be effective the date specified above. 
 Maker:

 Ampio Pharmaceuticals, Inc. 
  

			
	By:	 	 /s/ Donald B. Wingerter

		 	Donald B. Wingerter, Chief Executive Officer

 Holder:

 Michael Macaluso 
  

			
	By:	 	 /s/ Michael Macaluso

		 	Michael Macaluso
[Federal Register Volume 82, Number 181 (Wednesday, September 20, 2017)]
[Notices]
[Pages 43965-43966]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20098]


=======================================================================
-----------------------------------------------------------------------

FEDERAL ELECTION COMMISSION


Sunshine Act Meetings

FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: 82 FR 42682.

PREVIOUSLY ANNOUNCED TIME AND DATE OF THE MEETING: Thursday, September 
14, 2017 AT 11:15 a.m.

CHANGES IN THE MEETING: The meeting took place at 1:15 p.m.
    The Following Item Was Also Discussed: REG 2011-02 (Internet 
Communication Disclaimers).

[[Page 43966]]


CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, 
Telephone: (202) 694-1220.

Dayna C. Brown,
Secretary and Clerk of the Commission.
[FR Doc. 2017-20098 Filed 9-18-17; 11:15 am]
BILLING CODE 6715-01-P
<PAGE>

                                                                    Exhibit 32.1



                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report on Form 10-Q of Aspect Medical
Systems, Inc. (the "Company") for the period ended April 3, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, Nassib G. Chamoun, Chief Executive Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. Section 1350, that:

     (1)  the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.




                                                    /s/ Nassib G. Chamoun
                                                    ----------------------------
Dated: May 12, 2004                                 Nassib G. Chamoun
                                                    Chief Executive Officer



     A signed original of this written statement required by Section 906 has
been provided to Aspect Medical Systems, Inc. and will be retained by Aspect
Medical Systems, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Charles & Colvard, Ltd. (the Company) on Form 10-Q for the period ending March 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, James R. Braun, Vice President of Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                     
|-----------------------------------------------------
|/s/ James R. Braun                                   
|James R. Braun                                       
|Vice President of Finance and Chief Financial Officer
|May 7, 2008                                          



24
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1998
<CASH>                                      15,191,896
<SECURITIES>                                 5,839,883
<RECEIVABLES>                                  251,117
<ALLOWANCES>                                 1,436,316
<INVENTORY>                                 32,421,773
<CURRENT-ASSETS>                             5,724,429
<PP&E>                                       2,897,951
<DEPRECIATION>                              37,673,190
<TOTAL-ASSETS>                               6,763,642
<CURRENT-LIABILITIES>                          575,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                          121,180
<PREFERRED>                                          0
<COMMON>                                    46,232,376
<OTHER-SE>                                (15,867,763)
<TOTAL-LIABILITY-AND-EQUITY>                37,673,190
<SALES>                                      2,064,872
<TOTAL-REVENUES>                             8,439,336
<CGS>                                        1,659,702
<TOTAL-COSTS>                                3,465,223
<OTHER-EXPENSES>                             6,341,952
<LOSS-PROVISION>                                 4,000
<INTEREST-EXPENSE>                                 180
<INCOME-PRETAX>                            (1,285,586)
<INCOME-TAX>                                    58,452
<INCOME-CONTINUING>                        (1,344,038)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,344,038)
<EPS-PRIMARY>                                   (0.11)
<EPS-DILUTED>                                   (0.11)
        

</TABLE>
Order entered March 18, 2019

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-18-00131-CR

JEREMY DALE WILSON, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 366th Judicial District Court

Collin County, Texas

Trial Court Cause No. 366-80583-2017

ORDER

The State’s unopposed motion for extension of time to file brief is GRANTED. The 

State’s brief tendered with the motion is deemed FILED March 13, 2019. 

/s/ DAVID L. BRIDGES 

PRESIDING JUSTICE
I 

112TH CONGRESS 

1ST SESSION H. R. 2568 

To prevent the Secretary of the Treasury from expanding United States 

bank reporting requirements with respect to interest on deposits paid 

to nonresident aliens. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 15, 2011 

Mr. POSEY (for himself, Mr. MEEKS, and Mr. DIAZ-BALART) introduced the 

following bill; which was referred to the Committee on Ways and Means 

A BILL 

To prevent the Secretary of the Treasury from expanding 

United States bank reporting requirements with respect 

to interest on deposits paid to nonresident aliens. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PROHIBITION ON TREASURY REGULATIONS 

4 WITH RESPECT TO INFORMATION REPORT5 ING ON CERTAIN INTEREST PAID TO NON6 RESIDENT ALIENS. 

7 Except to the extent provided in Treasury Regula8 tions as in effect on February 21, 2011, the Secretary of 

9 the Treasury shall not require (by regulation or otherwise) 


rfrederick on DSKD9S0YB1PROD with BILLS
2 

•HR 2568 IH

1 that an information return be made by a payor of interest 

2 in the case of interest— 

3 (1) which is described in section 871(i)(2)(A) of 

4 the Internal Revenue Code of 1986, and 

5 (2) which is paid— 

6 (A) to a nonresident alien, and 

7 (B) on a deposit maintained at an office 

8 within the United States. 

Æ 


rfrederick on DSKD9S0YB1PROD with BILLS
<TABLE> <S> <C>

<ARTICLE>               5
<LEGEND>                
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-K OF
BERLITZ INTERNATIONAL, INC. FOR THE YEAR ENDED DECEMBER 31, 1998 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>            1,000
       
<S>                                             <C>
<PERIOD-TYPE>                                   12-MOS
<FISCAL-YEAR-END>                               DEC-31-1998
<PERIOD-END>                                    DEC-31-1998
<CASH>                                          25,327
<SECURITIES>                                    0
<RECEIVABLES>                                   48,945
<ALLOWANCES>                                    2,295
<INVENTORY>                                     11,606
<CURRENT-ASSETS>                                98,421
<PP&E>                                          66,674
<DEPRECIATION>                                  25,530
<TOTAL-ASSETS>                                  663,461
<CURRENT-LIABILITIES>                           105,717
<BONDS>                                         0
<COMMON>                                        1,003
<PREFERRED-MANDATORY>                           0
<PREFERRED>                                     0
<OTHER-SE>                                      353,983
<TOTAL-LIABILITY-AND-EQUITY>                    663,461
<SALES>                                         0
<TOTAL-REVENUES>                                436,303
<CGS>                                           0
<TOTAL-COSTS>                                   258,903
<OTHER-EXPENSES>                                17,265
<LOSS-PROVISION>                                0
<INTEREST-EXPENSE>                              10,956
<INCOME-PRETAX>                                 7,679
<INCOME-TAX>                                    5,665
<INCOME-CONTINUING>                             2,082
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                                    2,082
<EPS-PRIMARY>                                   0.22
<EPS-DILUTED>                                   0.22
        

</TABLE>